Plain-English translation of NCT06366828 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building prediction models to help doctors better understand which patients treated with radiation and chemotherapy for esophageal cancer are at higher risk for serious complications. By analyzing medical records from over 2,000 patients who have already received this treatment, the study aims to create tools that can help doctors personalize treatment plans and protect patients from preventable harm.
Even though radiation and chemotherapy combined with surgery can effectively treat esophageal cancer, these treatments carry risks of serious heart, lung, and surgical complications that vary greatly from person to person. This research exists to develop better ways to predict which patients are most vulnerable so doctors can adjust treatment plans individually and help patients make informed choices.
You likely qualify if…
You likely don't qualify if…
This is a data study, so you won't receive any new treatment. Researchers will ask your permission to combine information from your existing medical records, cancer registry data, and radiation treatment plans that you already have on file. If you are still living, you'll be asked to sign a consent form; if you have passed away, your data may be included unless you previously objected. No additional clinic visits or procedures are required.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Netherlands